Home > Analytics > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Intrinsic Value | Fundamental Analysis

BOM : 500288     NSE : MOREPENLAB    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Jan 27,2023
Price(EOD): ₹ 28.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,459.48 Cr
Value of ₹ 1 Lac invested in MOREPEN LABORATORIES
on Jan 29,2018 (price: ₹ 35.55)

₹ 1 L

₹ 0.80 L

1W : -8.6% 1M : -24.9% 1Y : -40.3%
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results
MOREPEN LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
MOREPEN LABORATORIES -8.6% -24.9% -40.3%
SUN PHARMACEUTICAL INDUSTRIES 1.3% 4.9% 30%
DIVIS LABORATORIES 1.3% -1.7% -17.5%
CIPLA -0.6% -3.5% 16%
DR REDDYS LABORATORIES -0.8% 1.5% -3.6%
TORRENT PHARMACEUTICALS -2.8% -2.4% 0.3%
ABBOTT INDIA -2.4% -2% 30.2%
ZYDUS LIFESCIENCES -1.7% 3.7% 7.4%
ALKEM LABORATORIES -1.1% -0.9% -13.9%

FUNDAMENTAL ANALYSIS OF MOREPEN LABORATORIES

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF MOREPEN LABORATORIES

 
Valuation Score
[As on : Jan 27,2023 ]

Ratio Consolidated
P/E
P/B
P/S
26.4
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 55.28 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

2.64
P/B Calculated based on Book Value of Rs 552.31 Cr
[Latest Year - Mar2022 - Consolidated Results ]

0.99
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,470.16 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 MOREPENLAB is one of the potential top 29% undervalued companies ! Discover More →

FAIR VALUE OF MOREPEN LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-25%
-43%
-20%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF MOREPEN LABORATORIES



MOREPEN LABORATORIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF MOREPEN LABORATORIES

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.03
0.04
0.04
0.04
0.03
0.04
0.05
0.04
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF MOREPEN LABORATORIES

Pledged Promoter Shares
0 %
As on : Dec2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF MOREPEN LABORATORIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
33.26%
98.74%
168.52%
180.82%
1.94%
-31.21%
-52.4%
-57.69%
QtrlyTrend
2
Latest Qtr: Sep2022
Quarterly Result Analysis →


MOREPEN LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -1.6% -2.2% -7.3%
S&P BSE ALLCAP -3.6% -3.5% -2%
S&P BSE MIDSMALLCAP -3.7% -3.3% -5.4%
S&P BSE SMALL CAP -4% -3.1% -7.8%
No NSE index found

You may also like the below Video Courses


FAQ about MOREPEN LABORATORIES


Is MOREPEN LABORATORIES good for long term investment?

As on Jan 27,2023, the Fundamentals of MOREPEN LABORATORIES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of MOREPEN LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MOREPEN LABORATORIES UnderValued or OverValued?

As on Jan 27,2023, MOREPEN LABORATORIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of MOREPEN LABORATORIES ?

As on Jan 27,2023, the Intrinsic Value of MOREPEN LABORATORIES is Rs. 38.20 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 38.20
Fair Value [Median EV / Sales Model] : Rs. 50.50
Fair Value [Median Price / Sales Model] : Rs. 35.49
Estimated Median Fair Value of MOREPEN LABORATORIES : Rs. 38.20

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is MOREPEN LABORATORIES trading at a Premium or Discount?

As on Jan 27,2023, MOREPEN LABORATORIES is trading at a Discount of -25% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].